PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Treatment reduces symptoms in syndrome that causes extreme light sensitivity

2015-07-02
(Press-News.org) (NEW YORK CITY - July 1, 2015) A novel synthetic hormone that makes certain skin cells produce more melanin significantly increases pain-free sun exposure in people with erythropoietic protoporphyria, a rare, genetic disorder resulting in excruciating pain within minutes of sun exposure. Two Phase III trials, conducted in Europe and in the United States by researchers at the Icahn School of Medicine at Mount Sinai and six other U.S. sites, showed that the duration of pain-free time in the sun and quality of life were significantly improved by treatment with afamelanotide, a novel synthetic version of a melanocyte-stimulating hormone. The findings were published in the July 2 issue of the New England Journal of Medicine.

"For patients worldwide, hiding from the sun for fear of debilitating pain is a fact of life, and for the first time we have an effective treatment for those who suffer from this specific porphyria," said lead study author Manisha Balwani, MD, Associate Professor of Genetics and Genomics Sciences and Medicine at the Icahn School of Medicine.

Symptoms of erythropoietic protoporphyria usually often first appear in early childhood. Patients experience severe, burning pain--typically on the hands and face--with sun exposure, followed by swelling and redness. The pain can be excruciating and is often is not alleviated by pain medications. Once patients learn to recognize early symptoms including tingling, burning, and itching, they avoid further sun exposure, with major implications for their daily activities, careers and quality of life.

"The data from these two Phase III trials conducted in Europe and in the U.S. support the effectiveness of this novel photo-protective drug, offering the patients in Europe--where the drug has been approved by the European Medicines Agency--the opportunity to perform their daily functions without the pain induced by sun exposure," said Robert J. Desnick, PhD, MD, Principal Investigator of the U.S. Trials and Dean for Genetic and Genomic Medicine, Icahn School of Medicine.

Researchers at Mount Sinai and in the European Union conducted two multicenter, randomized, double-blind, placebo-controlled trials of subcutaneous implants containing afamelanotide. Researchers randomly assigned 74 patients in the European Union and 94 in the United States to receive either afamelanotide or placebo implant every 60 days. The type and duration of sun exposure, number and severity of phototoxic reactions, and adverse events were recorded over the study periods. Quality of life was assessed with the use of validated questionnaires. The primary efficacy end point was the number of hours of direct exposure to sunlight without pain.

In the both the U.S. and European studies, the duration of pain-free time in sunlight was significantly longer in the afamelanotide groups. In the European study, the number of phototoxic reactions was significantly lower in the afamelanotide group. In both trials, quality of life improved with afamelanotide therapy. Adverse events were mostly mild and unrelated to the study drug.

INFORMATION:

The studies were funded by Clinuvel Pharmaceuticals; ClinicalTrials.gov numbers NCT01605136 and NCT00979745.

About the Mount Sinai Health System The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services--from community-based facilities to tertiary and quaternary care.

The System includes approximately 6,100 primary and specialty care physicians; 12 minority-owned free-standing ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is nationally ranked as one of the top 25 hospitals in 8 specialties in the 2014-2015 "Best Hospitals" issue of U.S. News & World Report. Mount Sinai's Kravis Children's Hospital also is ranked in seven out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked nationally, while Mount Sinai Beth Israel, Mount Sinai St. Luke's, and Mount Sinai Roosevelt are ranked regionally.

For more information, visit http://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.



ELSE PRESS RELEASES FROM THIS DATE:

Health information causing new mums anxiety

2015-07-02
Pregnancy and motherhood are both wonderful and worrisome times - could public health campaigns and social stereotypes be contributing to anxiety for mothers? Researchers from Monash University have identified links between perinatal anxiety and social and health messages that women are exposed to during the perinatal period, the period immediately before and after birth. In a paper recently published in Women's Studies International Forum, Dr Heather Rowe and Professor Jane Fisher from the Jean Hailes Research Unit within the School of Public Health and Preventive Medicine ...

Intrusiveness of old emotional memories can be reduced by computer game play procedure

2015-07-02
Unwanted, intrusive visual memories are a core feature of stress- and trauma-related clinical disorders such as posttraumatic stress disorder (PTSD), but they can also crop up in everyday life. New research shows that even once intrusive memories have been laid down, playing a visually-demanding computer game after reactivating the memories may reduce their occurrence over time. The findings are published in Psychological Science, a journal of the Association for Psychological Science. "This work is the first to our knowledge to show that a 'simple cognitive blockade' ...

In blinding eye disease, trash-collecting cells go awry, accelerate damage

In blinding eye disease, trash-collecting cells go awry, accelerate damage
2015-07-02
Spider-like cells inside the brain, spinal cord and eye hunt for invaders, capturing and then devouring them. These cells, called microglia, often play a beneficial role by helping to clear trash and protect the central nervous system against infection. But a new study by researchers at the National Eye Institute (NEI) shows that they also accelerate damage wrought by blinding eye disorders, such as retinitis pigmentosa. NEI is part of the National Institutes of Health. "These findings are important because they suggest that microglia may provide a target for entirely ...

The clock is ticking: New method reveals exact time of death after 10 days

2015-07-02
A new method for calculating the exact time of death, even after as much as 10 days, has been developed by a group of researchers at the University of Salzburg. Currently, there are no reliable ways to determine the time since death after approximately 36 hours. Initial results suggest that this method can be applied in forensics to estimate the time elapsed since death in humans. By observing how muscle proteins and enzymes degrade in pigs, scientists at the University of Salzburg have developed a new way of estimating time since death that functions up to at least ...

Research reveals how the human brain might reconstruct past events

2015-07-02
When remembering something from our past, we often vividly re-experience the whole episode in which it occurred. New UCL research funded by the Medical Research Council and Wellcome Trust has now revealed how this might happen in the brain. The study, published in Nature Communications, shows that when someone tries to remember one aspect of an event, such as who they met yesterday, the representation of the entire event can be reactivated in the brain, including incidental information such as where they were and what they did. "When we recall a previous life event, ...

Researchers find the macroscopic Brownian motion phenomena of self-powered liquid metal motors

Researchers find the macroscopic Brownian motion phenomena of self-powered liquid metal motors
2015-07-02
Classical Brownian motion theory was established over one hundred year ago, describing the stochastic collision behaviors between surrounding molecules. Recently, researchers from Technical Institute of Physics and Chemistry, Chinese Academy of Sciences discovered that the self-powered liquid metal motors in millimeter scale demonstrated similar Brownian like motion behaviors in alkaline solution. And the force comes from the hydrogen gas stream generated at the interface between liquid metal motor and its contacting substrate bottom. Ever since the irregular motions ...

Experts call for 'all hands on deck' to tackle global burden of non-communicable disease

2015-07-02
A group of the world's top doctors and scientists working in cardiology and preventive medicine have issued a call to action to tackle the global problem of deaths from non-communicable diseases (NCDs), such as heart problems, diabetes and cancer, through healthy lifestyle initiatives. They say that identifying the enormous burden caused by NCDs is not enough and it is time for "all hands on deck" to pursue strategies both within and outside traditional healthcare systems that will succeed in promoting healthier lifestyles in order to prevent or delay health conditions ...

Patient access to cardiovascular devices delayed by bureaucracy

2015-07-02
Sophia Antipolis, 02 July 2015: Patients are experiencing significant delays in access to approved cardiovascular devices due to bureaucratic inefficiencies, reveals a Devices White Paper from the Cardiovascular Round Table (CRT) published today in European Heart Journal.1 There is a clear correlation between declining death rates from cardiovascular disease and the introduction of innovative techniques and devices.1 The CRT is an independent forum established by the European Society of Cardiology (ESC) and comprised of cardiologists and representatives of the pharmaceutical, ...

Flying without wings: Losing feathers has a detrimental effect on migrating birds

Flying without wings: Losing feathers has a detrimental effect on migrating birds
2015-07-02
Birds that moult at the wrong time of the year could be disadvantaged, according to a study by scientists at Lund University, Sweden. Birds depend on a full set of feathers for maximum efficiency when flying long distances, but the study shows that moulting has a detrimental effect on their flight performance. The researchers trained a jackdaw to fly in a wind tunnel and measured different types of drag experienced by the bird. "We expected the bird not to be able to glide at the lowest speeds that it could glide at before moult and our results confirmed this", says ...

Simple classroom measures may reduce the impact of ADHD

2015-07-02
Children with Attention Deficit Hyperactivity Disorder (ADHD) may be successfully supported in classrooms through strategies that do not involve drugs, new research has indicated. These children are typically restless, act without thinking and struggle to concentrate, which causes particular problems for them and for others in school. A systematic review was led by the University of Exeter Medical School funded by NIHR's Health Research Technology Assessment programme and supported by the NIHR Collaboration for Leadership in Applied Health Research and Care South West ...

LAST 30 PRESS RELEASES:

Quantum fiber optics in the brain enhance processing, may protect against degenerative diseases

Icahn School of Medicine at Mount Sinai names Miriam Merad, MD, PhD, as Dean for Translational Research and Therapeutic Innovation

Details of hurricane Ian’s aftermath captured with new remote sensing method

Robots can’t outrun animals. A new study explores why

The Human Immunome Project unveils scientific plan to decode and model the immune system

New research funding awarded to assess the role of race in predicting heart disease

Exploring the role of seven key genes in breast cancer: insights from in silico and in vitro analyses

The therapeutic effects of baicalein on the hepatopulmonary syndrome in the rat model of chronic common bile duct ligation

Development and characterization of honey-containing nanoemulsion for topical delivery

Decoding cellular ‘shape-shifters’

"Seeing the invisible": new tech enables deep tissue imaging during surgery

After 25 years, researchers uncover genetic cause of rare neurological disease

Probing the effects of interplanetary space on asteroid Ryugu

T. rex not as smart as previously claimed, scientists find

Breakthrough in brown fat research: Researchers from Denmark and Germany have found brown fat’s “off-switch”

Tech Extension Co. and Tech Extension Taiwan to build next-generation 3D integration manufacturing lines using Tokyo Tech's BBCube Technology

Atomic nucleus excited with laser: a breakthrough after decades

Losing keys and everyday items ‘not always sign of poor memory’

People with opioid use disorder less likely to receive palliative care at end of life

New Durham University study reveals mystery of decaying exoplanet orbits

The threat of polio paralysis may have disappeared, but enterovirus paralysis is just as dangerous and surveillance and testing systems are desperately needed

Study shows ChatGPT failed when challenging ESCMID guideline for treating brain abscesses

Study finds resistance to critically important antibiotics in uncooked meat sold for human and animal consumption

Global cervical cancer vaccine roll-out shows it to be very effective in reducing cervical cancer and other HPV-related disease, but huge variations between countries in coverage

Negativity about vaccines surged on Twitter after COVID-19 jabs become available

Global measles cases almost double in a year

Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen

Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in treating a common form of irritable bowel syndrome, pilot study finds

Experts developing immune-enhancing therapies to target tuberculosis

Making transfusion-transmitted malaria in Europe a thing of the past

[Press-News.org] Treatment reduces symptoms in syndrome that causes extreme light sensitivity